Previous 10 | Next 10 |
home / stock / evax / evax articles
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $1...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,0...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday,...
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, bu...
Proof of Concept – Evaxion's AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological c...
EVX-01 is Evaxion's lead clinical asset based upon its AI-Immunology™ platform and has recently published a phase 2 clinical update c...
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian...
Initial EVX-01 Phase 2 data confirms the strong Phase 1 results After undergoing EVX-01 treatment, a significant and continuous tumor reduction...
Data from Evaxion's two personalized cancer vaccine clinical trials to be presented at the annual meeting of the Society for Immunotherapy o...
News, Short Squeeze, Breakout and More Instantly...
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art novel deep-learning framework as well as training on public and...
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders...
Positive Feedback Received: An International Preliminary Report on Patentability (IPRP) indicates promising prospects for obtaining granted patents and protecting the invention Unique Attributes and Inventiveness: The feedback highlights the distinct and inventive nature of all rele...